1
Kevin T Ousdigian, Vasant Padmanabhan, Paul J DeGroot, Walter H Olson, Vinod Sharma, Cameron J Kaszas, Paul G Krause: Combined anti-tachycardia pacing (ATP) and high voltage therapy for treating ventricular arrhythmias. Medtronic, Michael C Soldner, Girma Wolde Michael, May 10, 2005: US06892094 (41 worldwide citation)

A system and method for treating an arrhythmia of the heart, involves delivery of anti-tachy pacing (ATP) pulses to the heart, possibly followed by the delivery of a high-voltage shock. ATP delivery is controlled such that the time delivery of any high-voltage shock is not affected by the prior deli ...


2
Scott A Hareland, James K Carney, James D Reinke, Jon D Schell, Barbara J Schmid: Enabling and disabling anti-tachyarrhythmia pacing in a concomitant medical device system. Medtronic, December 19, 2017: US09844675

An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the de ...


3
James D Reinke, Glenn M Roline, Shohan T Hossain, Michael W Heinks: Anti-tachyarrhythmia shock detection. Medtronic, May 9, 2017: US09643024

An implantable pacemaker detects delivery of an anti-tachyarrhythmia shock by another device. The implantable pacemaker delivers cardiac stimulation therapy within a patient. The implantable pacemaker senses, via the electrode pair, an electrical signal. The implantable pacemaker detects the anti-ta ...


4
Kevin T Ousdigian, Vasant Padmanabhan, Paul J Degroot, Walter H Olson, Vinod Sharma, Cameron J Kaszas, Paul G Krause: Combined anti-tachycardia pacing (ATP) and high voltage therapy for treating ventricular arrhythmias. Medtronic, October 30, 2003: US20030204210-A1

The present invention provides a system and method for treating an arrhythmia of the heart. The system and method involves delivery of anti-tachy pacing (ATP) pulses to the heart, possibly followed by the delivery of a high-voltage shock. ATP delivery is controlled such that the time of delivery of ...


5
SYSTEMS AND METHODS FOR LEADLESS PACING AND SHOCK THERAPY. February 16, 2017: US20170043174-A1

Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical si ...


6
ENABLING AND DISABLING ANTI-TACHYARRHYTHMIA PACING IN A CONCOMITANT MEDICAL DEVICE SYSTEM. March 29, 2018: US20180085579-A1

An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the de ...


7
DETECTING AND RESPONDING TO ANTI-TACHYARRHYTHMIA SHOCKS. July 5, 2018: US20180185640-A1

In some examples, an implantable medical device determines that another medical device delivered an anti-tachyarrhythmia shock, and delivers post-shock pacing in response to the determination. The implantable medical device may be configured to both detect the delivery of the shock in a sensed elect ...